Introduction

II. A biochemical point of view
The significance of the heterogeneity of structure of gonadotrophin oligosaccharides and its impact on hormone function for clearance, tissue compatibility, and quantification of gonadotrophins. For a cell biologist, the significance of oligosaccharide heterogeneity is in its impact upon protein trafficking through the endoplasmic reticulum and Golgi apparatus, for glycoprotein recognition, or in how its associated Heterogeneity of gonadotrophin oligosaccharides caused glycan structures simply serve as the molecular fingerprint of either by pharmacological intervention or which occurs the repertoire of glycosyl-transferases within a particular gennaturally during normal physiological changes is well etic background. In this debate, the molecular point of view, documented. Recent advances in structure determinafrom a biochemical endocrinologist, is given. The interest is tion of oligosaccharides has to some extent led to a not only in the structures of the gonadotrophin isoforms, but better appreciation of how oligosaccharide heterogeneity how they affect protein folding and stability, their measurement, may affect protein folding, stability, measurement and and the nature of oligosaccharide unit interaction with either modulation of receptor binding. Here it is discussed how the gonadotrophin or its cognate receptor and whether these carbohydrate structure can impact upon gonadotrophin interactions affect the consummation of the signal transduction structure and function. It is well documented that event at the level of the cell membrane. oligosaccharides can serve as a cognate site for protein binding. One functional aspect of gonadotrophin glycos-
Structure and function of oligosaccharide heterogeneity ylation heterogeneity is the modulation of receptor
The dimensions of heterodimeric HCG are 75Åϫ35Åϫ30Å, binding affinity, yielding partially agonistic glycoforms.
thus a typical N-linked oligosaccharide measuring 30Å is Carbohydrate heterogeneity is problematic for a clinical expected to play a significant role in the functional properties chemist if immunochemical assays are sensitive to heteroof the gonadotrophins to which they are attached (Rudd et al., geneity. However, even measurements made without such 1999 ). Recent studies demonstrate that despite high local interference may not accurately reflect the biological flexibility, solvent reorganization is a key factor that can activity that is a collective result of all isoforms in stabilize distinct glycosidic linkage conformations (Woods the circulation, and perhaps of the genotype of each et al., 1998) . However, studying those conformations has been individual. Moreover, oligosaccharide heterogeneity may difficult. Despite the long residence time of these conformers affect heterodimer stability, therefore, biological activity as measured by nuclear magnetic resonance spectroscopy and immunochemical activity, not to mention clearance.
(NMR), unambiguous electron density for sugar ring carbons It seems reasonable to conclude that from a biochemical can usually only be assigned to the more rigid glycan cores point of view, oligosaccharide heterogeneity is of considin most X-ray crystal and NMR solution structures of glycoerable importance. However, accurate measurement of proteins. This difficulty has hindered a better understanding isoforms in blood, and appropriate in-vitro bioassays of glycoprotein hormone oligosaccharide structure and function that are insensitive to matrix effects are needed to define (Rudd et al., 1999) . For the three crystal structures of HCG the physiological significance of each glycoform, and that are available (GlcNAc -GlcNAcβ1) (Lapthorn et al., 1994; Wu et al., 1994; Tegoni et al., 1999) , and NMR structures thereby better define target therapeutics and interpret available for the ᭙-subunit (Wu et al., 1994; Erbel et al., diagnostic results.
2000) unambiguous electron density could only be assigned to
Key words: glycoforms/gonadotrophins/hormone physiology/oligocertain of the asparagine-proximal glycan core sugar residues.
saccharides However, recent breakthroughs in labelling strategies in mammalian cells and development of 'carbohydrate filtration' NMR methods has led to greater resolution of the glycan structures Oligosaccharide moieties bind to cellular proteins with high specificity, and N-linked oligosaccharides in particular moduon the α-subunit, both in isolation, and in complex with the β-subunit (Weller et al., 1996) This latter study provided two late the homo-and hetero-dimerization of glycoproteins (Qasba, 2000) . The preferred conformation of each asparagine important structural discoveries: the glycan moieties of the α-subunit beyond GlcNAc 2 act without conformational linked oligosaccharide chain about the α1→3 and α1→6 linkages determines the overall shape of the glycan moiety restraint due to interactions with the α-or β-subunit, and the enzymatic capping of galactose residues with the addition of and of the whole molecule (Qasba et al., 1997) . Conformational variance of the Manα1-3Manβ linkage is not affected by sialic acid did not alter the conformation of the glycan moieties.
substitutions on that antenna (Homans et al., 1987) . Hormone activity will be impacted by isoform-specific oligosaccharides Functional aspects of gonadotrophin glycosylation derived primarily from sugar residues distal to the glycosylation sequon (GalNAc-4-SO 4 [LH and TSH] and sialic acid [FSH] ). Discussion of the biochemical significance of the oligosaccharide heterogeneity of glycoprotein hormones is best
The gonadotrophin literature is replete with observations showing that removal of oligosaccharide from the αN52 site appreciated after reviewing the chemical nature of the carbohydrate on the glycoprotein hormones (Baenziger and Green, increases human follicle stimulating hormone (hFSH) binding to cognate receptor with a commensurate decrease in signal 1988). In addition, a full appreciation of the heterogeneity of oligosaccharides at each N-linked site can be obtained from transduction (Keene et al., 1994) . It is important to point out that although the importance of αN52 oligosaccharide in HCG NMR studies (Weisshaar et al., 1991a,b; Hiyama et al., 1992) . Moreover, any opinion rendered about the biochemical is established (Matzuk et al., 1989) , this is not the case with human thryroid stimulating hormone (hTSH). In this instance, significance of isoforms of the glycoprotein hormones would be best placed in a context of hormone action. Thus, a particular deletion of either of the α-subunit glycosylation sites does not decrease signal transduction, whereas deletion of both sites isoform must be at concentrations in blood that would allow for interaction with its cognate receptor. In the case of the simultaneously greatly impairs signal transduction (Fares et al., 1996) . The severity of the effect is directly related to the size follicle stimulating hormone (FSH) receptor, this would require nanomolar concentrations of each isoform of interest. Of of the Manα1-6, Man linkage at αN52 (Butnev et al., 1998) . This linkage, of all other glycosidic linkages studied, appears interest was a report that circulating concentrations of FSH isoform bioactivity did not correlate with immunoactivity to be less restrained, and at least three distinct conformers could be identified (Petrescu et al., 1999) . Orientation of the following treatment with gonadotrophin releasing hormone antagonist (Dahl et al., 1988) . Concentrations of isoforms in α1→6 arm is affected by rotation about both the π and ρ angles (Qasba et al., 1997) which is influenced by certain key blood have been determined at various stages of the menstrual cycle (Ulloa- Aguirre et al., 1995) . Since circulating concentraresidues (Homans et al., 1986) . Thus, in addition to enhancing stability of heterodimeric HCG, (Heikoop et al., 1998) , the tions of isoforms with varied biological activity do vary with pharmacological intervention, or phase of the menstrual cycle, size of the Manα1-6, Man linkage at αN52 appears key to affecting intermolecular interactions between hormone and and concentrations are nanomolar, it is appropriate to investigate whether a variety of mechanisms underlie various isoform receptor. It remains to be shown if such glycosylation variants occur in nature. activities.
It is well recognized that one of the major functions of Simply desialylating gonadotrophin and thereby removing the negatively charged sialic acid that caps the terminal oligosaccharides in biology is to serve as a recognition epitope for protein binding. Oligosaccharide molecular interactions galactose residues produces an increase in affinity with no effect on signal transduction. We have observed this to be true may include hydrophobic interactions, salt bridge formation, and hydrogen bonding. The glycoprotein hormone receptors when comparing highly purified pituitary hFSH and equally pure hFSH expressed in insect cells. Both were prepared in are also glycosylated (Libert et al., 1989; Mcfarland et al., 1989a; Sprengel et al., 1990) . If the T-cell receptors can serve this laboratory; the content of protein in each preparation was determined by amino acid analysis and the receptor binding as a paradigm, then glycosylation of the receptor may help prevent non-specific aggregation and provide a molecular activity of each preparation was compared using hFSH receptor expressed in Chinese hamster ovary cells (Kelton et al., 1992) scaffold that orients the binding face and leads to increased affinity (Rudd et al., 1999) . This role of carbohydrate on the (data not shown). High mannose forms of hFSH, produced in insect cells bound receptor with higher affinity than pituitary receptor seems offset by carbohydrate on the hormone that has less of a role in protein recognition, and more of a role in hFSH. These high mannose forms exhibited normal signal transduction properties compared to pituitary hFSH, (Ulloapreventing high affinity protein-receptor binding (dampener). The suggestion that the glycoprotein hormone receptors may Aguirre et al., 1999) in direct contrast to reports to the contrary (Arey et al., 1997) . Using anti-hFSH monoclonal antibody have a lectin-like activity (Mcfarland et al., 1989b) and that perhaps the hormone-attached carbohydrate moieties interact 46.3H6.B7 to capture hFSH and a polyclonal anti-α-subunitantibody to detect hFSH captured, little difference was observed with the transmembrane helices of the receptor (Sprengel et al., 1990) has not been substantiated experimentally. Although the between the immunoreactivity of each preparation (data not shown). Isoforms of hFSH that arise from heterogeneity search for lectin-like sequences in the receptor has not proven useful, there is no reason to assume that the receptor does beyond the Man 3 GlcNAc 2 core are therefore not expected to demonstrate more than a 10-fold difference in binding affinity. not interact with the hormone's associated carbohydrate.
Such isoforms are not likely to be recognized differently by consequence of this is that estimates of circulatory concentrations of the hormones may be greatly varied because of the monoclonal antibodies, although as discussed below, this is an issue of some controversy. Following this line of logic, isoforms plethora of antibodies used for these determinations. Whether the major effect of oligosaccharide variation on immune that are at concentrations at least as high as hFSH, and even in some cases, 10-fold lower, could reasonably give rise to a reactivity is seen when the oligosaccharide is completely removed or is equally affected by, for example, variation in significant biological effect in vivo.
the degree of sialylation, is an open question and one of some controversy (Storring, 1992; Jeffcoate, 1993) . Differences are Partially agonistic glycoforms most likely to be detected when the antibodies used are made against heavily glycosylated pituitary preparations of the As stated above, the biochemical significance of glycoforms of the carbohydrate atN52 appears to be related to the length glycoprotein hormones. A key appears to be the judicious selection of antibodies, either monoclonal, or perhaps antipepof its Man(α1-6)Man upper arm. Since forms of hormone with reduced size or no carbohydrate at αN52 bind receptor tide antibodies in pairs, which are directed to parts of the molecule that are well away from oligosaccharide attachment, with high affinity but with reduced signal transduction, they may be referred to as partial agonists that have only moderate but are not subject to proteolysis or conformational changes. With judicious use of antibodies, it seems unlikely that hormone intrinsic activity (Keene et al., 1994) . As a result, the maximal effect that a glycoprotein hormone partial agonist can produce isoforms will vary significantly in antibody immunoreactivity unless their stability is compromised, leading to subunit is lower than that of a full agonist. Unless partial agonist des αN52 glycoforms can be shown to exist in nature, they are dissociation. For example, antibodies can be generated that recognize carbohydrate moieties in addition to the peptide not likely to be physiologically significant. An early report suggested that isoforms of FSH exist, and could function as backbone. A good example of this is the crystal structure of two Fv (variable) fragments specific for the α and β subunits naturally occurring antagonists of FSH action (Dahl et al., 1988) . Recently, it has been shown that a basic isoform of complexed to HCG (Tegoni et al., 1999) . In this example, Ser26 from the anti-β Fv interacts with the first GlcNAc pituitary hFSH acts as a partial agonist, which can stimulate adenylate cyclase activity but blocks downstream effects such residue on Asn52 of the α-subunit. In this instance the structure anticipates the possibility that deglycosylation at Asn52 might as steroidogenesis and secretion of tissue plasminogen activator . Similar effects have been observed with affect that particular antibody reactivity with HCG. In an extensive examination of the differences between recombinant basic isoforms of hTSH (Medri et al., 1994) . It will be of great interest to determine the structure of the oligosaccharides and pituitary hTSH, it was demonstrated that certain peptide regions of recombinant hTSH were not detectable by antipepassociated with this particular glycoform, and whether the glycoform is present in the circulation. The structural nature tide antibodies, when compared to pituitary hTSH (Canonne et al., 1995) . It was found that the degree of sialylation may suggest previously unappreciated mechanisms of signal transduction that are modulated by oligosaccharide heteromarkedly affected measurement of hTSH. Thus removal of sialic acid did not alter the recognition of recombinant hTSH geneity. Since this isoform does not block adenylate cyclase activation, it is unlikely to couple preferentially to the inhibitory in various immunoassays, it did abolish binding of pituitary hTSH to anti-TSH monoclonal antibodies (Zerfaoui and Ronin, subunit Giα. Its ability to block Bt2 cyclic AMP (cAMP) effects may provide further evidence that alternate signalling 1996). This speaks directly to the issue of circulating isoform heterogeneity impact on measurement of blood concentrations pathways for FSH exist (Maizels et al., 1998) , and that cAMP enables or acts in concert with, but is not sufficient for the of glycoprotein hormones and the need to ascertain that one's assay is not confounded by sensitivity to isoform variation. activation of, these pathways.
In any case, it appears that glycoforms can have variable signal transduction capacities. A consequence of glycoform Oligosaccharide effects on specificity heterogeneity that presently cannot be determined is its effect When addressing issues about the physiological significance on: (i) final conformation of the hormone receptor complex; of oligosaccharide heterogeneity on gonadotrophin function, (ii) whether the hormone interacts with a lectin; (iii) if the specificity of HCG for the TSH receptor is a case in point. a particular glycoform predisposes the glycoform/receptor
The activity of HCG at the TSH receptor increases markedly complex to interact with an alternate signalling pathway other with desialylation (Reddy et al., 1996; Kraiem et al., 1997) . than an Gsα/adenylate cyclase pathway. This may be due to However, full deglycosylation decreases HCG ability to stimua specific carbohydrate-interaction with protein, or may arise late TSH receptor-mediated adenyl cyclase activity. Basic from steric hindrance. Thus, less steric hindrance by smaller isoforms of HCG were found to be more potent than native side chains may allow for tighter than normal binding that HCG at stimulating TSH receptor (Hoermann et al., 1995) . might lead to less than normal transduction.
One might predict that during pregnancy, changes in the isoform composition of HCG may impact upon thyroid function. Carbohydrate as the bane of a clinical chemist Protein stability As mentioned above, glycoform variation can affect the immunoreactivity of each glycoprotein hormone, making
Whether glycosylation affects intramolecular rearrangements during folding has been an open question. A comparison of measurement of glycoprotein hormones a challenge. The deglycosylated HCG structures with fully glycosylated HCG of oligosaccharides exist, changes in various physiological or pharmacological manipulations, and how this impacts upon revealed very similar overall backbone conformations (Tegoni et al., 1999) . However, in that study, it is not clear to what diagnostics and protein structure are tangible pragmatic aspects of a modern debate. How oligosaccharide heterogeneity, even extent the Fv molecules stabilized a particular conformer of the glycosylated HCG structure. Whether greater differences of currently available recombinant forms of gonadotrophins, impacts upon therapy can only be guessed at. In this regard, would have been observed if free fully glycosylated HCG had been studied is an open question. It was also of interest that the physiology of each patient and how they might respond to particular isoforms is key. Availability of recombinant forms in the crystal of the fully glycosylated HCG-Fv(2), two HCG molecules formed a two-fold related dimer, which was not of gonadotrophins does not obviate the question posed. In fact, the glycoform distribution of recombinant FSH suggests that reported in the two independent deglycosylated HCG structures. The surface contacts involved α-45-48 and β104-106.
further refinements in processing are likely and are of practical interest (Lambert et al., 1995) . From a practical point of Neither of these sequences has been implicated in receptor binding activity of the hormone. It seems likely that the most view, defining the target product will depend largely upon understanding the physiological significance of each glycogeneral effect of protein glycosylation is not on the overall protein fold, but may be an alteration in the dynamics or the form. The fact is, that from a biochemical point of view, a major benefit of recombinant gonadotrophins to the patient range of conformers possible of the peptide backbone structure.
The impact of individual oligosaccharides on hormone aside from decreased production cost is lack of contamination with other proteins and gonadotrophins and not a more uniform activity may occur through interaction with the protein backbone or side chains derived primarily from the influence of glycoform preparation (Hayden et al., 1999 ). Indeed, the next level of therapy might include blended mixtures where FSH the proximal sugar residues (Manβ1,4GlcNAcβ1,4GlcNAc core). Glycoforms can have variable conformational stability decreases with each dose and LH is held constant, as it has been shown that LH can continue follicle maturation in the as shown by NMR studies of glycosylation variants of HCG (van Zuylen et al., 1997) . For example, GlcNAcβ1,2 are the presence of diminishing FSH concentrations (Sullivan et al., 1999) . Thus the development of shorter acting forms of gonadprimary determinants for HCG within-subunit interactions. GlcNAcAsn78 of the α-subunit makes significant contacts otrophins with more rapid clearance and hence finer control of treatment, or even inhibitory forms of gonadotrophins, with the amino acids in the free α-subunit. In the heterodimer, the carbohydrate lies against the hydrophobic core formed which can be used to ameliorate ovarian hyperstimulation will largely depend upon basic knowledge obtained from what between the β-loops. It has been claimed that deglycosylated HCG is less active than fully glycosylated HCG because it is might be considered academic pursuits. Rational design of gonadotrophin therapy (now based largely on oestradiol proless stable at 37°C (Heikoop et al., 1998) . However, chemically deglycosylated sheep lutrophin has been reported to have duction as a response parameter), and accurate diagnosis of the mechanisms of infertility will require a better understanding greater thermal stability than fully glycosylated sheep lutrophin (Sairam and Manjunath, 1982) . Of course, there are many of whether there is a physiological role of gonadotrophin oligosaccharide heterogeneity. In this regard, generation of major differences between these two studies, including the species, the gonadotrophin, the extent of deglycosylation, as conditional knockout animals, deficient in glycosylation pathways may provide some insights. In this way, animals could be well as the fact that the sheep lutrophin is already properly folded when it is deglycosylated, whereas the HCG folded in reared to maturity, then induced to shut down oligosaccharide processing to study effects on reproduction. the cell without the benefit of oligosaccharide.
The presence or absence of oligosaccharide on the α-As pointed out above, development of immunoassays that can measure gonadotrophins without effect of glycosylation is subunit may affect conformation of a hydrophobic patch in the α-subunit (Lapthorn et al., 1994) . We have previously trivial. One only needs the appropriate antibody pairs. A practical consequence of the foregoing debate however, is that shown that when residues in the long loop of β-FSH that interact with this hydrophobic patch of the α-subunit are one recognizes now, that just as one measures the 'good' and 'bad' cholesterol, the future of infertility diagnosis may well substituted, the stability of the heterodimer is decreased (Roth and Dias, 1996) . Therefore it seems reasonable to suggest that find one measuring the 'good' and 'bad' gonadotrophins. The idea is predicated on the fact that gonadotrophin immunoreacstability may be compromised if lack of oligosaccharide at αN78 destabilises the conformation of the α-subunit hydrotivity, does not and in its current form of assay never will translate into gonadotrophin bioactivity. phobic patch.
Will it ever be possible to measure gonadotrophin activity from an individual, and determine if it will behave similarly Conclusions to another patient? There are problems here as well, particularly because these in-vitro bioassays are carried out in 'defined' A debate should stimulate further research on the most difficult and contentious of problems, such as the need to measure even 'serum free' media, they are not frequently done with cells of human origin, and the concentrations of receptor biological activity of isoforms in human blood and development of appropriate in-vitro bioassays that are insensitive to matrix expressed are so high that they do not replicate the invivo situation. Clearly, current research efforts are under the effects of blood. That endeavour will not be embarked upon without adequate compelling rationale, derived from spotlight. This debate should stimulate the development of bioassays that will be conducted in serum or even whole reductionist, mechanistic studies. The fact is that heterogeneity
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